Bill Bradley

Bill Bradley is a seasoned professional in the field of translational research and clinical biomarkers, currently serving as Senior Director of Translational Research & Clinical Biomarkers at Scorpion Therapeutics. Previously, Bill Bradley held multiple leadership roles at Cyteir Therapeutics, including Senior Director and Director of Translational Research. Additional experience includes serving as Associate Director of Translational Sciences and Senior Scientist at Constellation Pharmaceuticals, as well as roles as Postdoctoral Fellow at Roche Pharmaceuticals. Bill Bradley holds a Ph.D. in Molecular Biophysics & Biochemistry from Yale University and a B.S. in Biochemistry from Boston College.